U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06917131) titled 'Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension' on April 01.
Brief Summary: The study aims to evaluate the effect of the royal jelly on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.
Study Start Date: Sept. 18, 2024
Study Type: INTERVENTIONAL
Condition:
Hypertension
Cardiovascular Diseases (CVD)
Inflammation
Intervention:
DIETARY_SUPPLEMENT: Royal Jelly
Participants will receive 2 capsules ...